Sensitization of prostate cancer cells to TRAIL-mediated apoptosis by chalcones and dihydrochalcones suggest the potential role of these compounds in anticancer immune defense in which endogenous TRAIL takes part. This evidence concerns the gene TNFSF10 and Familial prostate cancer.